We are live on ! Find out more
TMO icon

Thermo Fisher Scientific

2,266 hedge funds and large institutions have $176B invested in Thermo Fisher Scientific in 2022 Q3 according to their latest regulatory filings, with 116 funds opening new positions, 927 increasing their positions, 863 reducing their positions, and 102 closing their positions.

New
Increased
Maintained
Reduced
Closed

14% more first-time investments, than exits

New positions opened: 116 | Existing positions closed: 102

13% more call options, than puts

Call options by funds: $1.47B | Put options by funds: $1.3B

7% more repeat investments, than reductions

Existing positions increased: 927 | Existing positions reduced: 863

0.97% more ownership

Funds ownership: 87.64%88.62% (+0.97%)

1% less funds holding

Funds holding: 2,2812,266 (-15)

5% less capital invested

Capital invested by funds: $186B → $176B (-$9.79B)

6% less funds holding in top 10

Funds holding in top 10: 253238 (-15)

Holders
2,266
Holders Change
-15
Holders Change %
-0.66%
% of All Funds
39.04%
Holding in Top 10
238
Holding in Top 10 Change
-15
Holding in Top 10 Change %
-5.93%
% of All Funds
4.1%
New
116
Increased
927
Reduced
863
Closed
102
Calls
$1.47B
Puts
$1.3B
Net Calls
+$166M
Net Calls Change
+$177M
Name Holding Trade Value Shares
Change
Change in
Stake
BRCM
801
Bright Rock Capital Management
Massachusetts
$4.82M
ASN
802
Advisory Services Network
Georgia
$4.82M +$415K +742 +8%
MYLI
803
Meiji Yasuda Life Insurance
Japan
$4.81M +$206K +368 +4%
IDP
804
In-Depth Partners
Florida
$4.8M +$288K +514 +6%
LNWWM
805
Laird Norton Wetherby Wealth Management
California
$4.79M +$64.9K +116 +1%
PJSIMP
806
P.J. Schmidt Investment Management (PJS)
Wisconsin
$4.77M +$25.7K +46 +0.5%
PCA
807
Providence Capital Advisors
North Carolina
$4.77M -$762K -1,361 -13%
QIM
808
Quest Investment Management
Oregon
$4.76M +$1.34M +2,387 +34%
BFPW
809
BOK Financial Private Wealth
Colorado
$4.73M +$430K +769 +9%
FIM
810
Freedom Investment Management
Connecticut
$4.73M +$56K +100 +1%
TCM
811
Twin Capital Management
Pennsylvania
$4.68M -$109K -195 -2%
RBA
812
Richard Bernstein Advisors
New York
$4.67M -$1.07M -1,909 -17%
AUB
813
Atlantic Union Bankshares
Virginia
$4.67M -$788K -1,408 -13%
BFEC
814
Benjamin F. Edwards & Company
Missouri
$4.66M -$24.1K -43 -0.5%
VAS
815
Vestmark Advisory Solutions
Massachusetts
$4.63M +$78.9K +141 +2%
BKA
816
Brick & Kyle Associates
Pennsylvania
$4.61M -$14.6K -26 -0.3%
Acadian Asset Management
817
Acadian Asset Management
Massachusetts
$4.6M +$851K +1,521 +20%
MNBTD
818
Moody National Bank Trust Division
Texas
$4.59M +$44.8K +80 +0.9%
CIC
819
Canal Insurance Company
South Carolina
$4.57M
CA
820
Claar Advisors
New York
$4.57M
JIR
821
James Investment Research
Ohio
$4.55M -$16.8K -30 -0.3%
UFA
822
US Financial Advisors
Massachusetts
$4.54M -$53.2K -95 -1%
BCM
823
Becker Capital Management
Oregon
$4.47M
RWA
824
River Wealth Advisors
Pennsylvania
$4.46M -$327K -585 -6%
CCP
825
Corient Capital Partners
California
$4.44M

TMO Hedge Fund Activity: Q3 2022 in Review

2,266 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Thermo Fisher Scientific (TMO) for Q3 2022, worth a combined $176B — down 5.3% from $186B a quarter earlier.

Buyers outnumbered sellers: 116 funds opened new TMO positions and 102 closed out — a net gain of 14 holders — while 927 added to existing stakes and 863 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $795M. The largest seller was T. Rowe Price Associates, cutting an estimated $2.12B.

  • 2,266 institutional investors held Thermo Fisher Scientific (TMO) as of Q3 2022, down from 2,281 in Q2 2022.
  • Funds reported $176B of Thermo Fisher Scientific stock for Q3 2022, down 5.3% quarter-over-quarter.
  • 116 funds opened new Thermo Fisher Scientific positions in Q3 2022 and 102 closed out, a net change of +14 holders.
  • The largest Thermo Fisher Scientific buyer in Q3 2022 was Janus Henderson Group, an estimated $795M added.
  • The largest Thermo Fisher Scientific seller in Q3 2022 was T. Rowe Price Associates, an estimated $2.12B sold.

Based on aggregated 13F filings for Q3 2022.